US Stock MarketDetailed Quotes

DMAC DiaMedica Therapeutics

Watchlist

6.410
+1.540+31.62%

Close Dec 20 16:00 ET

5.650
-0.760-11.86%

Post 19:58 ET

274.10MMarket Cap-11.45P/E (TTM)

DiaMedica Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

6.82%-4.47M

10.16%-4.52M

-30.73%-6.65M

-62.70%-18.73M

-37.82%-3.81M

-103.18%-4.8M

-101.52%-5.03M

-30.89%-5.09M

6.05%-11.51M

1.36%-2.77M

Net income from continuing operations

-40.33%-6.27M

-14.34%-5.12M

2.30%-5.15M

-41.72%-19.38M

-37.59%-5.16M

-46.16%-4.47M

-33.32%-4.48M

-50.29%-5.27M

-0.62%-13.68M

-15.56%-3.75M

Depreciation and amortization

25.00%10K

42.86%10K

14.29%8K

20.00%30K

33.33%8K

14.29%8K

16.67%7K

4.17%25K

0.00%6K

Other non cash items

5.56%19K

11.76%19K

5.88%18K

9.38%70K

5.88%18K

12.50%18K

6.25%17K

13.33%17K

10.34%64K

13.33%17K

Change In working capital

546.18%1.58M

161.23%447K

-2,808.62%-1.69M

-84.10%93K

81.47%1.23M

-218.06%-353K

-267.82%-730K

93.00%-58K

226.90%585K

5,130.77%680K

-Change in receivables

182.79%101K

106.11%8K

-220.00%-30K

-697.92%-287K

-742.86%-59K

-1,038.46%-122K

-263.75%-131K

165.79%25K

-77.14%48K

73.08%-7K

-Change in prepaid assets

165.83%287K

-99.30%2K

-106.19%-1.47M

-196.30%-160K

775.00%700K

-240.19%-436K

12.99%287K

-1.72%-711K

56.10%-54K

-42.45%80K

-Change in payables and accrued expense

479.02%1.19M

149.32%437K

-130.41%-191K

-8.63%540K

-2.31%593K

920.00%205K

-977.23%-886K

782.61%628K

207.85%591K

707.00%607K

Cash from discontinued investing activities

Operating cash flow

6.82%-4.47M

10.16%-4.52M

-30.73%-6.65M

-62.70%-18.73M

-37.82%-3.81M

-103.18%-4.8M

-101.52%-5.03M

-30.89%-5.09M

6.05%-11.51M

1.36%-2.77M

Investing cash flow

Cash flow from continuing investing activities

-566.97%-5.59M

116.84%4.74M

67.72%4.21M

-258.60%-18.3M

29.64%6.12M

-42.28%1.2M

-1,212.66%-28.13M

13.32%2.51M

156.18%11.54M

154.37%4.72M

Net PPE purchase and sale

10.00%-9K

--0

-28.57%-9K

70.37%-24K

90.63%-3K

76.74%-10K

33.33%-4K

---7K

-305.00%-81K

-357.14%-32K

Net investment purchase and sale

-562.35%-5.58M

116.84%4.74M

67.61%4.22M

-257.29%-18.28M

28.83%6.13M

-42.98%1.21M

-1,209.87%-28.12M

13.64%2.52M

156.63%11.62M

154.78%4.76M

Cash from discontinued investing activities

Investing cash flow

-566.97%-5.59M

116.84%4.74M

67.72%4.21M

-258.60%-18.3M

29.64%6.12M

-42.28%1.2M

-1,212.66%-28.13M

13.32%2.51M

156.18%11.54M

154.37%4.72M

Financing cash flow

Cash flow from continuing financing activities

2,150.00%123K

-68.11%11.75M

0.00%-1K

614,133.33%36.84M

0.00%-1K

-200.00%-6K

1,842,600.00%36.85M

0.00%-1K

-100.02%-6K

94.74%-1K

Net issuance payments of debt

-50.00%-3K

0.00%-2K

0.00%-1K

0.00%-6K

0.00%-1K

0.00%-2K

0.00%-1K

0.00%-6K

0.00%-1K

Net common stock issuance

--0

----

--36.85M

--0

---4K

----

--0

Proceeds from stock option exercised by employees

--126K

----

--0

----

Cash from discontinued financing activities

Financing cash flow

2,150.00%123K

-68.11%11.75M

0.00%-1K

614,133.33%36.84M

0.00%-1K

-200.00%-6K

1,842,600.00%36.85M

0.00%-1K

-100.02%-6K

94.74%-1K

Net cash flow

Beginning cash position

140.90%14.07M

-2.33%2.1M

-3.91%4.54M

0.45%4.73M

-19.45%2.23M

90.69%5.84M

-29.19%2.15M

0.45%4.73M

-36.47%4.71M

-82.92%2.77M

Current changes in cash

-175.35%-9.93M

224.19%11.97M

5.23%-2.45M

-980.95%-185K

18.09%2.31M

-1,139.52%-3.61M

12,206.67%3.69M

-54.09%-2.58M

100.78%21K

117.00%1.96M

End cash Position

85.22%4.13M

140.90%14.07M

-2.33%2.1M

-3.91%4.54M

-19.45%2.23M

90.69%5.84M

-29.19%2.15M

0.45%4.73M

Free cash flow

6.82%-4.48M

10.23%-4.52M

-30.73%-6.66M

-61.77%-18.75M

-36.35%-3.82M

-99.96%-4.81M

-101.20%-5.03M

-31.07%-5.1M

5.56%-11.59M

0.46%-2.8M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	6.82%-4.47M	10.16%-4.52M	-30.73%-6.65M	-62.70%-18.73M	-37.82%-3.81M	-103.18%-4.8M	-101.52%-5.03M	-30.89%-5.09M	6.05%-11.51M	1.36%-2.77M
Net income from continuing operations	-40.33%-6.27M	-14.34%-5.12M	2.30%-5.15M	-41.72%-19.38M	-37.59%-5.16M	-46.16%-4.47M	-33.32%-4.48M	-50.29%-5.27M	-0.62%-13.68M	-15.56%-3.75M
Depreciation and amortization	25.00%10K	42.86%10K	14.29%8K	20.00%30K	33.33%8K	14.29%8K	16.67%7K	16.67%7K	4.17%25K	0.00%6K
Other non cash items	5.56%19K	11.76%19K	5.88%18K	9.38%70K	5.88%18K	12.50%18K	6.25%17K	13.33%17K	10.34%64K	13.33%17K
Change In working capital	546.18%1.58M	161.23%447K	-2,808.62%-1.69M	-84.10%93K	81.47%1.23M	-218.06%-353K	-267.82%-730K	93.00%-58K	226.90%585K	5,130.77%680K
-Change in receivables	182.79%101K	106.11%8K	-220.00%-30K	-697.92%-287K	-742.86%-59K	-1,038.46%-122K	-263.75%-131K	165.79%25K	-77.14%48K	73.08%-7K
-Change in prepaid assets	165.83%287K	-99.30%2K	-106.19%-1.47M	-196.30%-160K	775.00%700K	-240.19%-436K	12.99%287K	-1.72%-711K	56.10%-54K	-42.45%80K
-Change in payables and accrued expense	479.02%1.19M	149.32%437K	-130.41%-191K	-8.63%540K	-2.31%593K	920.00%205K	-977.23%-886K	782.61%628K	207.85%591K	707.00%607K
Cash from discontinued investing activities
Operating cash flow	6.82%-4.47M	10.16%-4.52M	-30.73%-6.65M	-62.70%-18.73M	-37.82%-3.81M	-103.18%-4.8M	-101.52%-5.03M	-30.89%-5.09M	6.05%-11.51M	1.36%-2.77M
Investing cash flow
Cash flow from continuing investing activities	-566.97%-5.59M	116.84%4.74M	67.72%4.21M	-258.60%-18.3M	29.64%6.12M	-42.28%1.2M	-1,212.66%-28.13M	13.32%2.51M	156.18%11.54M	154.37%4.72M
Net PPE purchase and sale	10.00%-9K	--0	-28.57%-9K	70.37%-24K	90.63%-3K	76.74%-10K	33.33%-4K	---7K	-305.00%-81K	-357.14%-32K
Net investment purchase and sale	-562.35%-5.58M	116.84%4.74M	67.61%4.22M	-257.29%-18.28M	28.83%6.13M	-42.98%1.21M	-1,209.87%-28.12M	13.64%2.52M	156.63%11.62M	154.78%4.76M
Cash from discontinued investing activities
Investing cash flow	-566.97%-5.59M	116.84%4.74M	67.72%4.21M	-258.60%-18.3M	29.64%6.12M	-42.28%1.2M	-1,212.66%-28.13M	13.32%2.51M	156.18%11.54M	154.37%4.72M
Financing cash flow
Cash flow from continuing financing activities	2,150.00%123K	-68.11%11.75M	0.00%-1K	614,133.33%36.84M	0.00%-1K	-200.00%-6K	1,842,600.00%36.85M	0.00%-1K	-100.02%-6K	94.74%-1K
Net issuance payments of debt	-50.00%-3K	0.00%-2K	0.00%-1K	0.00%-6K	0.00%-1K	0.00%-2K	0.00%-2K	0.00%-1K	0.00%-6K	0.00%-1K
Net common stock issuance	--0	----	----	--36.85M	--0	---4K	----	----	--0	--0
Proceeds from stock option exercised by employees	--126K	----	----	----	----	--0	----	----	----	----
Cash from discontinued financing activities
Financing cash flow	2,150.00%123K	-68.11%11.75M	0.00%-1K	614,133.33%36.84M	0.00%-1K	-200.00%-6K	1,842,600.00%36.85M	0.00%-1K	-100.02%-6K	94.74%-1K
Net cash flow
Beginning cash position	140.90%14.07M	-2.33%2.1M	-3.91%4.54M	0.45%4.73M	-19.45%2.23M	90.69%5.84M	-29.19%2.15M	0.45%4.73M	-36.47%4.71M	-82.92%2.77M
Current changes in cash	-175.35%-9.93M	224.19%11.97M	5.23%-2.45M	-980.95%-185K	18.09%2.31M	-1,139.52%-3.61M	12,206.67%3.69M	-54.09%-2.58M	100.78%21K	117.00%1.96M
End cash Position	85.22%4.13M	140.90%14.07M	-2.33%2.1M	-3.91%4.54M	-3.91%4.54M	-19.45%2.23M	90.69%5.84M	-29.19%2.15M	0.45%4.73M	0.45%4.73M
Free cash flow	6.82%-4.48M	10.23%-4.52M	-30.73%-6.66M	-61.77%-18.75M	-36.35%-3.82M	-99.96%-4.81M	-101.20%-5.03M	-31.07%-5.1M	5.56%-11.59M	0.46%-2.8M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--